Recent advances in diagnosis and management of Mycotic Keratitis
Prafulla K Maharana1, Namrata Sharma2, Ritu Nagpal3, Vishal Jhanji4, Sujata Das5, Rasik B Vajpayee6
1 Department of Ophthalmology, All India Institute of Medical Sciences, Bhubaneswar, India 2 Cornea and Refractive Services, Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India 3 Department of Ophthalmology, L.V. Prasad Eye Institute, Hyderabad, India 4 Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China 5 Department of Ophthalmology, L.V. Prasad Eye Institute, Bhubaneswar, India 6 Department of Ophthalmology, Vision Eye Institute, Royal Victorian Eye and Ear Hospital, North West Academic Centre, University of Melbourne, Australia
Correspondence Address:
Prof. Rasik B Vajpayee Vision Eye Institute, Royal Victorian Eye and Ear Hospital, North West Academic Centre, University of Melbourne Australia
Source of Support: None, Conflict of Interest: None | Check |
DOI: 10.4103/0301-4738.185592
|
Mycotic keratitis is a major cause of corneal blindness, especially in tropical and subtropical countries. The prognosis is markedly worse compared to bacterial keratitis. Delayed diagnosis and scarcity of effective antifungal agents are the major factors for poor outcome. Over the last decade, considerable progress has been made to rapidly diagnose cases with mycotic keratitis and increase the efficacy of treatment. This review article discusses the recent advances in diagnosis and management of mycotic keratitis with a brief discussion on rare and emerging organisms. A MEDLINE search was carried out for articles in English language, with the keywords, mycotic keratitis, fungal keratitis, emerging or atypical fungal pathogens in mycotic keratitis, investigations in mycotic keratitis, polymerase chain reaction in mycotic keratitis, confocal microscopy, treatment of mycotic keratitis, newer therapy for mycotic keratitis. All relevant articles were included in this review. Considering the limited studies available on newer diagnostic and therapeutic modalities in mycotic keratitis, case series as well as case reports were also included if felt important. |